Cytokine-induced epithelial permeability changes are regulated by the activation of the p38 mitogen-activated protein kinase pathway in cultured caco-2 cells

Shock

Volumn 29, Issue 4, 2008, Pages 531-537

  Wang, Quan ^a,b   Guo, Xia Ling ^a   Wells Byrum, Denise ^a   Noel, Greg ^a   Pritts, Timothy A ^b   Ogle, Cora K ^a,b  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Caco 2 cells; Cytokine; ERK; JNK; NO; p38 MAPK; Permeability

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 NITROPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; HEAT SHOCK PROTEIN 27; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM; HUMAN; HUMAN CELL; INTESTINE MUCOSA PERMEABILITY; PROTEIN PHOSPHORYLATION;

CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIUM; HUMANS; IMIDAZOLES; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PYRIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 40949086461     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318150737f     Document Type: Article

References (37)

1. Beyaert R, Cuenda A, Vanden Berghe W, Plaisance S, Lee JC, Haegeman G, Cohen P, Fiers W: The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J 15:1914-1923, 1996.
2. Garat C, Arend WP: Intracellular IL-1Ra type 1 inhibits IL-1-induced IL-6 and IL-8 production in Caco-2 intestinal epithelial cells through inhibition of p38 mitogen-activated protein kinase and NF-kappaB pathways. Cytokine 23:31-40, 2003.
3. Shuai K: Modulation of STAT signaling by STAT-interacting proteins. Oncogene 19:2638-2644, 2000.
4. Shuai K, Liao J, Song MM: Enhancement of antiproliferative activity of gamma interferon by the specific inhibition of tyrosine dephosphorylation of Stat1. Mol Cell Biol 16:4932-4941, 1996.
5. Goh KC, Haque SJ, Williams BR: p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons. EMBO J 18:5601-5608, 1999.
6. Adams RB, Planchon SM, Roche JK: IFN-gamma modulation of epithelial barrier function. Time course, reversibility, and site of cytokine binding. J Immunol 150:2356-2363, 1993.
7. Madara JL, Stafford J: Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 83:724-727, 1989.
8. Yang H, Kiristioglu I, Fan Y, Forbush B, Bishop DK, Antony PA, Zhou H, Teitelbaum DH: Interferon-gamma expression by intraepithelial lymphocytes results in a loss of epithelial barrier function in a mouse model of total parenteral nutrition. Ann Surg 236:226-234, 2002.
9. Gitter AH, Bendfeldt K, Schmitz H, Schulzke JD, Bentzel CJ, Fromm M: Epithelial barrier defects in HT-29/B6 colonic cell monolayers induced by tumor necrosis factor-alpha. Ann N Y Acad Sci 915:193-203, 2000.
10. Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, Nusrat A: Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 171:6164-6172, 2003.
11. Chavez AM, Menconi MJ, Hodin RA, Fink MP: Cytokine-induced intestinal epithelial hyperpermeability: role of nitric oxide. Crit Care Med 27:2246-2251, 1999.
12. Han X, Fink MP, Delude RL: Proinflammatory cytokines cause NO*-dependent and-independent changes in expression and localization of tight junction proteins in intestinal epithelial cells. Shock 19:229-237, 2003.
13. Karlsen AE, Ronn SG, Lindberg K, Johannesen J, Galsgaard ED, Pociot F, Nielsen JH, Mandrup-Poulsen T, Nerup J, Billestrup N: Suppressor of cytokine signaling 3 (SOCS-3) protects beta-cells against interleukin-1beta- and interferon-gamma-mediated toxicity. Proc Natl Acad Sci U S A 98:12191-12196, 2001.
14. Wang Q, Guo XL, Noel G, Ogle C: Heat shock stress ameliorates cytokine mixture-induced permeability by downregulating the nitric oxide and signal transducer and activator of transcription pathways in Caco-2 cells. Shock 27:179-185, 2007.
15. Pratt SL, Ogle CK, Mao JX, Zhao W, Lovell G, Horseman ND: Interleukin-6 signal transduction in human intestinal epithelial cells. Shock 13:435-440, 2000.
16. Sanders SE, Madara JL, McGuirk DK, Gelman DS, Colgan SP: Assessment of inflammatory events in epithelial permeability: a rapid screening method using fluorescein dextrans. Epithelial Cell Biol 4:25-34, 1995.
17. Wang Q, Fang CH, Hasselgren PO: Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice. Am J Physiol Regul Integr Comp Physiol 281:R1013-R1023, 2001.
18. Kyriakis JM, Avruch J: Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81:807-869, 2001.
19. Saklatvala J: The p38 MAP kinase pathway as a therapeutic target in inflammatory disease. Curr Opin Pharmacol 4:372-377, 2004.
20. Niwa M, Hotta K, Kanamori Y, Hatakeyama D, Hirade K, Katayama M, Hara A, Mori H, Ito H, Kato K, et al.: Involvement of p38 mitogen-activated protein kinase in heat shock protein 27 induction in human neutrophils. Eur J Pharmacol 466:245-253, 2003.
21. Carter AB, Monick MM, Hunninghake GW: Both Erk and p38 kinases are necessary for cytokine gene transcription. Am J Respir Cell Mol Biol 20:751-758, 1999.
22. Wuyts WA, Vanaudenaerde BM, Dupont LJ, Demedts MG, Verleden GM: Involvement of p38 MAPK, JNK, p42/p44 ERK and NF-kappaB in IL-1beta-induced chemokine release in human airway smooth muscle cells. Respir Med 97:811-817, 2003.
23. Hall JP, Davis RJ: Inhibition of the p38 pathway upregulates macrophage JNK and ERK activities, and the ERK, JNK, and p38 MAP kinase pathways are reprogrammed during differentiation of the murine myeloid M1 cell line. J Cell Biochem 86:1-11, 2002.
24. Suzuki M, Tetsuka T, Yoshida S, Watanabe N, Kobayashi M, Matsui N, Okamoto T: The role of p38 mitogen-activated protein kinase in IL-6 and IL-8 production from the TNF-alpha-or IL-1beta-stimulated rheumatoid synovial fibroblasts. FEBS Lett 465:23-27, 2000.
25. Young PR, McLaughlin MM, Kumar S, Kassis S, Doyle ML, McNulty D, Gallagher TF, Fisher S, McDonnell PC, Carr SA, et al.: Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J Biol Chem 272:12116-12121, 1997.
26. Lee JC, Kassis S, Kumar S, Badger A, Adams JL: p38 mitogen-activated protein kinase inhibitors-mechanisms and therapeutic potentials. Pharmacol Ther 82:389-397, 1999.
27. Frantz B, Klatt T, Pang M, Parsons J, Rolando A, Williams H, Tocci MJ, O'Keefe SJ, O'Neill EA: The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding. Biochemistry 37:13846-13853, 1998.
28. Mahtani KR, Brook M, Dean JL, Sully G, Saklatvala J, Clark AR: Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol Cell Biol 21:6461-6469, 2001.
29. Newton R, Holden N: Inhibitors of p38 mitogen-activated protein kinase: potential as anti-inflammatory agents in asthma? BioDrugs 17:113-129, 2003.
30. Song GY, Chung CS, Jarrar D, Chaudry IH, Ayala A: Evolution of an immune suppressive macrophage phenotype as a product of P38 MAPK activation in polymicrobial sepsis. Shock 15:42-48, 2001.
31. Song GY, Chung CS, Chaudry IH, Ayala A: MAPK p38 antagonism as a novel method of inhibiting lymphoid immune suppression in polymicrobial sepsis. Am J Physiol Cell Physiol 281:C662-C669, 2001.
32. Badger AM, Bradbeer JN, Votta B, Lee JC, Adams JL, Griswold DE: Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J Pharmacol Exp Ther 279:1453-1461, 1996.
33. Parhar K, Ray A, Steinbrecher U, Nelson C, Salh B: The p38 mitogen-activated protein kinase regulates interleukin-1beta-induced IL-8 expression via an effect on the IL-8 promoter in intestinal epithelial cells. Immunology 108:502-512, 2003.
34. Bhat NR, Zhang P, Bhat AN: Cytokine induction of inducible nitric oxide synthase in an oligodendrocyte cell line: role of p38 mitogen-activated protein kinase activation. J Neurochem 72:472-478, 1999.
35. Poljakovic M, Nygren JM, Persson K: Signalling pathways regulating inducible nitric oxide synthase expression in human kidney epithelial cells. Eur J Pharmacol 469:21-28, 2003.
36. Maruo N, Morita I, Shirao M, Murota S: IL-6 increases endothelial permeability in vitro. Endocrinology 131:710-714, 1992.
37. Yang R, Han X, Uchiyama T, Watkins SK, Yaguchi A, Delude RL, Fink MP: IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. Am J Physiol Gastrointest Liver Physiol 285:G621-G629, 2003.